Stock Market Reviews

Read and share opinions on CLGN (CollPlant Biotechnologies Ltd.) stock. Join MyTopStock.com to discover reviews, insights, and discussions from investors about this company's performance in the stock

Latest News

• CollPlant Expands its rhCollagen Distribution Capabilities in the United States and Canada
  Oct 27, 2025
• CollPlant's rhCollagen-Based BioInk Demonstrates Strong Performance Compared to Matrigel® in Study Conducted by Technion - Israel Institute of Technology
  Oct 20, 2025
• First-in-Kind Fully Humanized 3D Bioprinted Human Skin Model Developed by Mayo Clinic Researchers using CollPlant's rhCollagen-Based BioInk
  Oct 16, 2025
• One CollPlant Biotechnologies Insider Raised Their Stake In The Previous Year
  Oct 3, 2025
• CollPlant Biotechnologies Announces Positive Results from non-clinical Studies of its Photocurable Regenerative Dermal and Soft Tissue Filler
  Sep 30, 2025
• CollPlant Expands the Distribution of its VergenixSTR Product in Europe
  Sep 15, 2025
• CollPlant to Present at the 2025 International Conference on Biofabrication
  Sep 2, 2025
• CollPlant to Participate in the Upcoming 27th Annual H.C. Wainwright Global Investment Conference
  Aug 25, 2025
• COLLPLANT BIOTECHNOLOGIES REPORTS 2025 SECOND QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
  Aug 20, 2025
• COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR SECOND QUARTER FINANCIAL RESULTS
  Aug 5, 2025
• CollPlant Appoints Collagen Biomaterials Expert as New Head of North America Commercial Operations
  Jul 14, 2025
• COLLPLANT BROADENS ITS COLLABORATION WITH STEMCELL TECHNOLOGIES
  Jun 9, 2025
• COLLPLANT BIOTECHNOLOGIES ANNOUNCES EUROPEAN PATENT ALLOWANCE SECURED FOR ITS COLLAGEN-BASED FORMULATIONS USABLE AS SOFT TISSUE FILLERS AND IMPLANTS
  Jun 4, 2025
• COLLPLANT BIOTECHNOLOGIES ANNOUNCES $3.6 MILLION REGISTERED DIRECT OFFERING PRICED AT-THE-MARKET UNDER NASDAQ RULES
  May 30, 2025
• CollPlant Biotechnologies First Quarter 2025 Earnings: Misses Expectations
  May 29, 2025
• COLLPLANT BIOTECHNOLOGIES REPORTS 2025 FIRST QUARTER FINANCIAL RESULTS AND PROVIDES A CORPORATE UPDATE
  May 28, 2025
• COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR FIRST QUARTER FINANCIAL RESULTS
  May 14, 2025
• CollPlant's Collink.3D® BioInks and Technologies Offer a Relevant and Timely Solution to FDA's Plan to Reduce Animal Testing in Preclinical Safety Studies
  Apr 15, 2025